[1]
C. Fozza, V. Crobu, G. Caocci, G. La Nasa, G. Sotgiu, and L. Saderi, “A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemia”, MJHID, vol. 11, no. 1, p. e2019032, Apr. 2019.